MwanzoDEVA • IST
add
Deva Holding AS
Bei iliyotangulia
₺ 67.45
Bei za siku
₺ 67.60 - ₺ 69.15
Bei za mwaka
₺ 51.00 - ₺ 81.75
Thamani ya kampuni katika soko
13.68B TRY
Wastani wa hisa zilizouzwa
elfu 588.66
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
IST
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (TRY) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 5.49B | -2.19% |
Matumizi ya uendeshaji wa biashara | 1.74B | 2.67% |
Mapato halisi | -1.34B | -524.24% |
Kiwango cha faida halisi | -24.48 | -537.50% |
Mapato kwa kila hisa | — | — |
EBITDA | 622.26M | -48.71% |
Asilimia ya kodi ya mapato | -294.28% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (TRY) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 3.59B | 26.49% |
Jumla ya mali | 37.63B | -3.31% |
Jumla ya dhima | 11.31B | -3.14% |
Jumla ya hisa | 26.32B | — |
hisa zilizosalia | 200.02M | — |
Uwiano wa bei na thamani | 0.51 | — |
Faida inayotokana na mali | -0.61% | — |
Faida inayotokana mtaji | -0.70% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (TRY) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -1.34B | -524.24% |
Pesa kutokana na shughuli | 1.49B | 27.32% |
Pesa kutokana na uwekezaji | -838.87M | -130.98% |
Pesa kutokana na ufadhili | 260.62M | 117.90% |
Mabadiliko halisi ya pesa taslimu | 885.62M | 206.74% |
Mtiririko huru wa pesa | -165.38M | 95.31% |
Kuhusu
DEVA Holding A.Ş. is a leading Turkish pharmaceutical company founded in 1958. As of 2024, it ranked 3rd in unit sales and 6th in TL sales in Turkey’s pharmaceutical market.
The company operates three EU GMP- and US FDA-approved facilities in Çerkezköy and Kartepe, with an annual production capacity of 620 million units. DEVA’s portfolio covers 10 therapeutic areas, including cardiovascular, dermatology, ophthalmology, hematology, and anti-infectives, and includes 1,404 registered products across 82 countries.
Recognized as Turkey’s top pharmaceutical company in R&D spending by Turkishtime’s 2024 R&D 250 Report, DEVA employs over 500 researchers and 3,000 staff in total. Guided by sustainability and innovation, the company focuses on developing accessible, effective, and environmentally responsible healthcare solutions for both domestic and global markets. Wikipedia
Ilianzishwa
22 Sep 1958
Tovuti
Wafanyakazi
3,023
